Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 37976 - 38000 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	NOP16	51491	upregulated	entinostat results in increased expression of NOP16 mRNA	5q35.2	A21037
Entinostat	Investigational	NOS1	4842	upregulated	entinostat results in increased expression of NOS1 mRNA	12q24.22	A21037
Entinostat	Investigational	NOSTRIN	115677	upregulated	entinostat results in increased expression of NOSTRIN mRNA	2q24.3	A21035
Entinostat	Investigational	NOTCH2	4853	upregulated	entinostat results in increased expression of NOTCH2 mRNA	1p12	A21035
Entinostat	Investigational	NOTCH2NL	388677	upregulated	entinostat results in increased expression of NOTCH2NL mRNA	1q21.1	A21035
Entinostat	Investigational	NOVA1	4857	downregulated	entinostat results in decreased expression of NOVA1 mRNA	14q12	A21037
Entinostat	Investigational	NPAS4	266743	downregulated	entinostat results in decreased expression of NPAS4 mRNA	11q13.2	A21037
Entinostat	Investigational	NPFFR2	10886	upregulated	entinostat results in increased expression of NPFFR2 mRNA	4q13.3	A21037
Entinostat	Investigational	NPL	80896	upregulated	entinostat results in increased expression of NPL mRNA	1q25.3	A21035
Entinostat	Investigational	NPTX1	4884	upregulated	entinostat results in increased expression of NPTX1 mRNA	17q25.3	A21037
Entinostat	Investigational	NPTX2	4885	upregulated	entinostat results in increased expression of NPTX2 mRNA	7q22.1	A21037 A21035
Entinostat	Investigational	NPTXR	23467	upregulated	entinostat results in increased expression of NPTXR mRNA	22q13.1	A21035
Entinostat	Investigational	NPY	4852	upregulated	entinostat results in increased expression of NPY mRNA	7p15.3	A21035
Entinostat	Investigational	NPY2R	4887	downregulated	entinostat results in decreased expression of NPY2R mRNA	4q32.1	A21037
Entinostat	Investigational	NPY2R	4887	upregulated	entinostat results in increased expression of NPY2R mRNA	4q32.1	A21035
Entinostat	Investigational	NQO1	1728	upregulated	entinostat results in increased expression of NQO1 mRNA	16q22.1	A21037
Entinostat	Investigational	NQO2	4835	upregulated	entinostat results in increased expression of NQO2 mRNA	6p25.2	A21037
Entinostat	Investigational	NR2C1	7181	downregulated	entinostat results in decreased expression of NR2C1 mRNA	12q22	A21037
Entinostat	Investigational	NR2F1	7025	downregulated	entinostat results in decreased expression of NR2F1 mRNA	5q15	A21037
Entinostat	Investigational	NR2F1-AS1	441094	downregulated	entinostat results in decreased expression of NR2F1-AS1 mRNA	5q15	A21037
Entinostat	Investigational	NR2F2	7026	downregulated	entinostat results in decreased expression of NR2F2 mRNA	15q26.2	A21037
Entinostat	Investigational	NR3C1	2908	upregulated	entinostat results in increased expression of NR3C1 mRNA	5q31.3	A21037
Entinostat	Investigational	NRAV	100506668	upregulated	entinostat results in increased expression of NRAV mRNA	12q24.31	A21037
Entinostat	Investigational	NRCAM	4897	downregulated	entinostat results in decreased expression of NRCAM mRNA	7q31.1	A21037
Entinostat	Investigational	NREP	9315	downregulated	entinostat results in decreased expression of NREP mRNA	5q22.1	A21035

Displaying entries 37976 - 38000 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability